Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 196323
Corporate User License Price USD 4500
Corporate User License Price INR 321255
Site License Price USD 3500
Site License Price INR 249865
Request a Quote

Report Title

Point-of-Care Diagnostics Market 2018-2024

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Point-of-Care Diagnostics Market 2018-2024


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Point-of-Care Diagnostics Market 2018-2024

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Point-of-Care Diagnostics Market 2018-2024



Executive Summary

Global Point-of-Care Diagnostics Market-Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024

Overview: Point-of-care diagnostic test, also referred to as bedside testing or near-patient testing, is a medical diagnostic test conducted outside the laboratory at or near the place where the patient is receiving care. These tests are usually performed by non-laboratory personnel and test results are used for clinical decision making. The complexity and procedures for POC diagnostics may vary from manual methodologies to automated analyzers. These tests are comparatively more expensive than typical laboratory tests but are convenient and cost effective in some clinical settings since these are performed in close proximity to the patient. The best part is that these tests give immediate decisions for clinical management. According to a report released by the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or prediabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. There is an increase in life style diseases and developing countries are also suffering from such ailments. It is primarily because of the increasing adoption of Western lifestyle which is expected to fuel the growth of point-of-care diagnostics market in near future.

The point-of-care diagnostics market is booming due to several factors such as the growing patient base for lifestyle diseases globally, growing elderly population, increasing prevalence of infectious disease, technological innovations and increasing adoption of point-of-care diagnostics. Stringent approval processes, unfavorable reimbursement scenarios and product recalls are some of the factors hampering the market growth. The market in emerging countries is expected to grow at a rapid pace during the forecast period because of increasing healthcare awareness towards point-of-care diagnostics, increasing healthcare spending and growing patient pool.

Market Analysis: The Global Point-of-Care Diagnostics Market is estimated to witness a CAGR of 7.7% during the forecast period 2018-2024. The market is analyzed based on four segments -products, prescription mode, end-users and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is set to be the leading region for the Point-of-Care Diagnostics market growth followed by Europe, Asia Pacific and the rest of the world.

Product Analysis: The global Point-of-Care Diagnostics market by product is segmented into glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, coagulation monitoring kits, tumor/cancer markers, cholesterol test strips, drugs-of-abuse testing kits, and others. Glucose monitoring kits occupied the largest share in 2017 due to factors such as an increase in the prevalence of diabetes, change in lifestyle, growing elderly population and increasing demand for disease management.

Prescription Mode Analysis: The global point-of-care diagnostics market by prescription mode is segmented into Prescription-based POC diagnostics and OTC-based POC diagnostics. The latter has occupied a major market share since 2017 and is expected to retain its position during the forecasted period with the introduction of hand-held and portable devices and increased awareness of POC diagnostics.

End-Users Analysis: The global point-of-care diagnostics market by end-users is segmented into hospitals, clinics, home-care and others. Hospitals occupied the maximum market share in 2017 and is expected to be same for the next few years.

Key Players: Abbott Laboratories, F. Hoffmann-La Roche, Johnson & Johnson, Siemens AG, Danaher Corporation, Qiagen N.V., BioMerieux S.A., Nova Biomedical, Beckton Dickinson and Company, Trinity Biotech plc and other niche players.

Competitive Analysis: Currently, the glucose monitoring kits dominate the global point-of-care diagnostics market. A lot of new players are concentrating on this market to deliver advanced and innovative products. The key market players are acquiring other companies to enhance their product portfolio and strengthen their leadership position in the market. For instance, in October 2017, Abbott completed the acquisition of Alere for about USD 5.3 billion. In January 2017, Werfen acquired Accriva Diagnostics, a global leader in in vitro diagnostic (IVD) blood testing at the Point-of-Care (POC). The acquisition included Accriva's flagship product portfolio spanning coagulation, platelet aggregation, CO-Oximetry and incision devices. Not only this but key players are also launching new products to have an edge in the market. For instance, in January 2018, Abbott Laboratories announced the launch of CE marked Alinity h-series integrated system for hematology testing.

Benefits: The report provides complete details about the usage and adoption rate of point-of-care diagnostics products in various regions. With the help of this report, key stakeholders will find extensive details about the major trends, drivers, investments and vertical players' initiatives. It will also shed light on government initiatives toward the test adoption in the upcoming years along with the details of commercial tests available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on the market growth. Additionally, the report gives in-depth information about the key business opportunities to key stakeholders so that they can expand their businesses and forecast the revenue in specific verticals before investing or expanding their businesses in this market.

Key Stakeholders:

Table of Contents

1 INDUSTRY OUTLOOK 9

1.1 Industry overview 10

1.2 Total addressable market 10

1.3 Industry Trends 11

2 Report Outline 11

2.1 Report Scope 11

2.2 Report Summary 12

2.3 Research Methodology 12

2.4 Report Assumptions 13

3 Market Snapshot 14

3.1 Market Definition-Infoholic Research 14

3.2 Advantages of Point-of-care testing 14

3.3 Disadvantages of Point-of-care testing 14

3.4 Segmented Addressable Market (SAM) 14

3.5 Trends of the point-of-Care diagnostics market 15

3.6 Related Markets 16

3.6.1 Molecular diagnostics 16

3.6.2 Infectious disease diagnostics 16

4 Market Outlook 16

4.1 Overview 16

4.2 Funding scenario 17

4.3 Market segmentation 19

4.4 PEST Analysis 19

4.5 Porter 5(Five) Forces 21

5 Market Characteristics 22

5.1 DRO-Global Point-of-care Diagnostics Market Dynamics 22

5.1.1 Drivers 22

5.1.1.1 Increasing prevalence of infectious disease 22

5.1.1.2 Growing incidence of life-style disease 23

5.1.1.3 Technological innovations 23

5.1.1.4 Increasing adoption of point-of-care diagnostics 24

5.1.2 Opportunities 24

5.1.2.1 Growth opportunities in emerging markets 24

5.1.2.2 Increasing awareness towards point-of-care diagnostics in developing countries 25

5.1.3 Restraints 25

5.1.3.1 Stringent approval process 25

5.1.3.2 Product recalls 26

5.1.3.3 Unfavorable reimbursement scenario 26

6 Product: Market Size and Analysis 29

6.1 Overview 29

6.2 Glucose monitoring kits 31

6.3 Infectious disease testing kits 32

6.4 Pregnancy and fertility testing kits 33

6.5 Hematology testing kits 35

6.6 Cardiometabolic monitoring kits 35

6.7 Urinalysis testing kits 37

6.8 Coagulation monitoring kits 38

6.9 Tumour or cancer marker testing kits 39

6.10 Cholesterol testing kits 40

6.11 Drugs of abuse testing kits 40

6.12 Others 41

7 Prescription mode: Market Size and Analysis 42

7.1 Overview 42

7.2 Prescription-based point-of-care diagnostics 44

7.3 Over the counter-based point-of-care diagnostics 45

8 End Users: Market Size and Analysis 46

8.1 Overview 46

8.2 Hospitals 47

8.3 Clinics 47

8.4 Home-care 48

8.5 Others 48

9 Regions: Market Size and Analysis 49

9.1 Overview 49

9.2 North America 50

9.2.1 Overview 50

9.2.2 US 51

9.2.3 Canada 52

9.3 Europe 52

9.3.1 Overview 52

9.3.2 UK 53

9.3.3 Germany 53

9.3.4 France 54

9.3.5 Spain 54

9.4 APAC 54

9.4.1 Overview 54

9.4.2 India 55

9.4.3 China 56

9.5 Rest of the World 56

10 Competitive Landscape 57

10.1 Overview 57

11 Vendor Profiles 61

11.1 Abbott Laboratories 61

11.1.1 Overview 61

11.1.2 Business Unit 64

11.1.3 Geographic Presence 65

11.1.4 Business Focus 66

11.1.5 SWOT Analysis 67

11.1.6 Business Strategy 67

11.2 F.Hoffmann-La Roche Ltd 68

11.2.1 Overview 68

11.2.2 Business Unit 71

11.2.3 Geographic Presence 72

11.2.4 Business Focus 73

11.2.5 SWOT Analysis 73

11.2.6 Business Strategy 74

11.3 Johnson & Johnson 75

11.3.1 Overview 75

11.3.2 Business Units 78

11.3.3 Geographic Revenue 79

11.3.4 Business Focus 80

11.3.5 SWOT Analysis 81

11.3.6 Business Strategies 81

11.4 Danaher Corporation 82

11.4.1 Overview 82

11.4.2 Business Unit 86

11.4.3 Geographic Presence 86

11.4.4 Business Focus 87

11.4.5 SWOT Analysis 88

11.4.6 Business Strategy 88

11.5 Siemens Healthineers Inc. (Siemens AG) 89

11.5.1 Overview 89

11.5.2 Business Units 92

11.5.3 Geographic Presence 94

11.5.4 Business Focus 94

11.5.5 SWOT Analysis 95

11.5.6 Business Strategy 95

12 Companies to Watch For 96

12.1 Trinity Biotech plc 96

12.1.1 Overview 96

12.1.2 Trinity Biotech plc: Recent Developments 97

12.2 Qiagen N.V. 97

12.2.1 Overview 97

12.2.2 Qiagen N.V.: Recent Developments 97

12.3 BioMerieux S.A. 101

12.3.1 Overview 101

12.3.2 BioMerieux S.A.: Recent Developments 102

12.4 OraSure Technologies, Inc. 103

12.4.1 Overview 103

12.4.2 OraSure Technologies, Inc.: Recent Developments 104

12.5 Instrumentation Laboratory (a Werfen company) 104

12.5.1 Overview 104

12.5.2 Instrumentation Laboratory: Recent Developments 105

12.6 Becton Dickinson and Company 106

12.6.1 Overview 106

12.6.2 Becton dickenson and company: Recent Developments 107

12.7 Nova Biomedical 107

12.7.1 Overview 107

12.7.2 Nova Biomedical: Recent Developments 108

13 Annexure 110

13.1 Abbreviations 110

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 12

CHART 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE, 2017-2024 (USD MILLION) 15

CHART 3 PEST ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 19

CHART 4 PORTER 5 FORCES ON GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 21

CHART 5 DRO-IMPACT ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 26

CHART 6 KEY STAKEHOLDERS 27

CHART 7 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRODUCT, 2017 V/S 2024 (USD ) 29

CHART 8 GLOBAL GLUCOSE MONITORING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 31

CHART 9 GLOBAL INFECTIOUS DISEASE TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 33

CHART 10 GLOBAL PREGNANCY AND FERTILITY TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 34

CHART 11 GLOBAL HEMATOLOGY TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 35

CHART 12 GLOBAL CARDIOMETABOLIC MONITORING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 36

CHART 13 GLOBAL URINALYSIS TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 37

CHART 14 GLOBAL COAGULATION MONITORING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 38

CHART 15 GLOBAL TUMOUR OR CANCER MARKER TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 39

CHART 16 GLOBAL CHOLESTEROL TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 40

CHART 17 GLOBAL DRUGS OF ABUSE TESTING KITS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 41

CHART 18 GLOBAL OTHERS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 42

CHART 19 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRESCRIPTION MODE, 2017 (%) 42

CHART 20 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRESCRIPTION MODE, 2024 (%) 43

CHART 21 GLOBAL PRESCRIPTION-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 44

CHART 22 GLOBAL OTC-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 45

CHART 23 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY END-USERS SEGMENTATION, 2017 (%) 46

CHART 24 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 49

CHART 25 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 50

CHART 26 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN EUROPE, 2017-2024 (USD MILLION) 52

CHART 27 POINT-OF-CARE DIAGNOSTICS REVENUE IN ASIA-PACIFIC, 2017-2024 (USD MILLION) 55

CHART 28 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2017-2024 (USD MILLION) 56

CHART 29 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 64

CHART 30 ABBOTT LABORATORIES.: BUSINESS UNITS 64

CHART 31 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 65

CHART 32 ABBOTT LABORATORIES.: SWOT ANALYSIS 67

CHART 37 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 78

CHART 38 JOHNSON & JOHNSON: BUSINESS UNITS 78

CHART 39 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 79

CHART 40 JOHNSON & JOHNSON: SWOT ANALYSIS 81

CHART 41 DANAHER CORPORATION: OVERVIEW SNAPSHOT 85

CHART 42 DANAHER CORPORATION: BUSINESS UNITS 86

CHART 43 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 86

CHART 44 DANAHER CORPORATION: SWOT ANALYSIS 88

CHART 45 SIEMENS AG: OVERVIEW SNAPSHOT 91

CHART 46 SIEMENS AG: BUSINESS UNITS 92

CHART 47 SIEMENS AG: GEOGRAPHIC PRESENCE 94

CHART 48 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 95

Tables

TABLE 1 FUNDING SCENARIO 17

TABLE 1 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCTS, 2017-2024 (USD MILLION) 30

TABLE 1 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE, 2017-2024 (USD MILLION) 44

TABLE 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE BY REGIONS, 2017-2024 (USD MILLION) 49

TABLE 3 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY VENDOR RANKING, 2017 59

TABLE 4 OTHER PROMINENT VENDORS OF POINT-OF-CARE DIAGNOSTICS MARKET 60

TABLE 5 ABBOTT LABORATORIES: PRODUCT OFFERINGS 61

TABLE 6 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 62

TABLE 7 F. HOFFMANN-LA ROCHE: OFFERINGS 68

TABLE 8 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 69

TABLE 9 JOHNSON & JOHNSON: PRODUCT OFFERINGS 75

TABLE 10 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 76

TABLE 11 DANAHER CORPORATION: OFFERINGS 82

TABLE 12 DANAHER CORPORATION: RECENT DEVELOPMENTS 84

TABLE 13 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 89

TABLE 14 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 90

TABLE 15 TRINITY BIOTECH PLC: SNAPSHOT 96

TABLE 16 QIAGEN N.V.: SNAPSHOT 97

TABLE 17 BIOMERIEUX S.A.: SNAPSHOT 101

TABLE 18 ORASURES TECHNOLOGIES: SNAPSHOT 103

TABLE 19 INSTRUMENTATION LABORATORY: SNAPSHOT 104

TABLE 20 BECTON DICKINSON AND COMPANY: SNAPSHOT 106

TABLE 21 NOVA BIOMEDICAL: SNAPSHOT 107

?

Abbott Laboratories, F. Hoffmann-La Roche, Johnson & Johnson, Siemens AG, Danaher Corporation, Qiagen N.V., BioMerieux S.A., Nova Biomedical, Beckton Dickinson and Company, Trinity Biotech plc and other niche players


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person